ArticlePharmacoEconomics - open2023

A Budget Impact Model of Maintenance Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with IgPro20 (Hizentra) Relative to Intravenous Immunoglobulin in the United States.

Rajiv Mallick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.